Antimicrobial surveillance may be defined as a systematic collection, analysis, and dissemination of data that may be used to identify resistance trends and assess the need for intervention (2). In 1988 the Centers for Disease Control and Prevention published guidelines for evaluation of surveillance systems for antimicrobial resistance (7), and an American Society for Microbiology task force (1) highlighted the importance of performing antimicrobial surveillance through local, national, and global networks. Unfortunately, the recommendations from this task force were not implemented, in part due to lack of funding (6). To this end, however, international as well as more than 21 national programs designed to capture susceptibility data for most clinically significant organisms (e.g., SENTRY and TSN) and 24 programs that focused on specific organisms (e.g., CARE and TRUST), were identified in 1999 through the
No takes yet. Share an insight, caveat, or question.
Halstead et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: